News

SAN DIEGO–(BUSINESS WIRE)– #advancedtherapies–Launching Excellos, an innovative cell and gene therapy CDMO, pairing collection of human cells/tissues with manufacturing and development services Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O’Neill brings extensive experience leading Quality,… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Reports Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Trial Click here to view original post… […]

TAIPEI and SAN DIEGO: TAIPEI and SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced today that the US Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 24, 2022 /PRNewswire/ — The first molecular electronics chip has been developed, realizing a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law. Developed by Roswell Biotechnologies and a multi-disciplinary team of leading academic scientists, the chip… Click here to view original post… […]

CARLSBAD, Calif.: CARLSBAD, Calif., Jan. 24, 2022 /PRNewswire/ — DCN Dx announced today that Mitzi Rettinger has been hired as chief revenue officer reporting directly to Chief Executive Officer Charlie Mamrak. "Mitzi brings decades of sales and marketing experience to the chief revenue officer role," Mamrak said. "She is a… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 24, 2022 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its Phase 1b clinical trial of VK0214 in patients with X-linked adrenoleukodystrophy (X-ALD) has been placed… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 Click here to view original post… […]

CARLSBAD, Calif.: CARLSBAD, Calif., Jan. 24, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to eplontersen, an investigational antisense medicine for the treatment of people living with transthyretin-mediated amyloidosis, a… Click here to view original post… […]

LA JOLLA—The Salk Institute announced today the appointment of Julie A. Auger to the position of executive director of Research Operations. Auger will oversee all shared scientific resources at the Institute in her new role, including the scientific technology cores, animal research and shared scientific resources. The position reports… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 21, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from a Phase 2 cohort of the KRYSTAL-1 study evaluating adagrasib at the 600mg BID dose in patients with pretreated pancreatic ductal adenocarcinoma and other gastrointestinal (GI)… Click here to view original post… […]

John Maraganore ? The needle on the Maraganore Meter is moving again, as John Maraganore keeps collecting more post-Alnylam roles. First, he and BeiGene co-founder Peter Ho will be strategic advisors for Hillhouse-backed China startup Overland Pharmaceuticals, founded by Hua Mu and Ed Zhang. (By the… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 20, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company has completed a pre-investigational new drug (Pre-IND) meeting with the U.S. Food and… Click here to view original post… […]

When Bo Jing enrolled at Oxford University to be close to his girlfriend, he didn’t expect to invent something that would have investors eagerly digging into their wallets. He was just happy making the best microscope he could. He developed the technology while finishing up his PhD at Oxford, and… Click here to view original post… […]

BOSTON: BOSTON, Jan. 20, 2022 /PRNewswire/ — Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for treating concussion, today announced two new board members and additions to its executive leadership team. The company also announced its corporate headquarters’ move from San Diego to Boston…. Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy approaches initially focused on non-invasive detection of high-mortality cancers, today announced positive performance evaluation study results for its pancreatic cancer test. These data confirm that its pancreatic cancer test detects the… Click here to view original post… […]

TAIPEI and SAN DIEGO: TAIPEI and SAN DIEGO, Jan. 20, 2022 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Silmitasertib,… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Jan. 20, 2022 /PRNewswire/ — BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the appointment of Sahm Nasseri as Chief Business Officer. "Sahm is an accomplished biopharma leader with impressive experience in business development, corporate strategy, commercialization and… Click here to view original post… […]

A spin-out of Oxford University, ONI’s desktop microscopy platform aims to help researchers and life sciences firms zoom in on single molecules in living cells to better develop therapies. Click here to view original post… […]